Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.1000 (-5.65%) ($40.1000 - $42.5000) on Wed. Sep. 10, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.16% (three month average) | RSI | 53 | Latest Price | $40.1000(-5.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.08% in a week (0% probabilities). VIXM(-5%) TLT(-4%) UUP(-2%) GLD(-2%) SLV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.08% (StdDev 4.16%) | Hourly BBV | 0 () | Intraday Trend | -5.6% | | | |
|
Resistance Level | $41.92 | 5 Day Moving Average | $41.22(-2.72%) | 10 Day Moving Average | $41.99(-4.5%) | 20 Day Moving Average | $41.92(-4.34%) | To recent high | -10.9% | To recent low | 4.2% | Market Cap | $790m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |